CASH interview | Professor Jinghui Zhang: Monitoring clonal hematopoiesis in pediatric patients to help improve long-term prognosis

CASH interview | Professor Jinghui Zhang: Monitoring clonal hematopoiesis in pediatric patients to help improve long-term prognosis

Clonal hematopoiesis usually refers to myeloid cell proliferation caused by genetic mutations in hematopoietic stem cells, and is also the basis of the pathogenesis of various blood diseases; monitoring clonal hematopoiesis can enable early detection of hematological malignancies. At the 4th CASH held recently, Professor Jinghui Zhang from St. Jude Children's Research Hospital shared the report "Treatment-Related Clonal Hematopoiesis in Adult Survivors of Childhood Cancer". After the meeting, " Oncology Frontier-Hematology Frontier" specially invited Professor Jinghui Zhang to give an in-depth sharing on the treatment-related causes, monitoring value and long-term impact of clonal hematopoiesis.